Latest Institute of Cancer Research Stories
A blood test that can read genetic results much like a ‘barcode’ has been developed by scientists at the Institute of Cancer Research and the Royal Marsden NHS Foundation.
A whole-genome scan to identify large-scale chromosomal damage can help doctors choose the best treatment option for children with neuroblastoma, one of the most common types of childhood cancer.
A new drug combination could offer hope to children with neuroblastoma – one of the deadliest forms of childhood cancer – by boosting the effectiveness of a promising new gene-targeted treatment.
Some say the number of cases is growing at an epidemic rate! In fact, melanoma is the fastest growing cancer in the U.S.
The human body does a great job of generating new cells to replace dead ones but it is not perfect. Cells need to communicate with or signal to each other to decide when to generate new cells.
In the largest study of its kind, researchers have profiled genetic changes in cancer with drug sensitivity in order to develop a personalised approach to cancer treatments.
In trying to unlock the potential of retinoids to treat patients with acute myeloid leukemia (AML), scientists have found the antidepressant called tranylcypromine (TCP) may be the key.
- A trick or prank.